Pegasus Asset Management’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-26,958
| Closed | -$87.3K | – | 68 |
|
|
2024
Q3 | $87.3K | Hold |
26,958
| – | – | 0.03% | 70 |
|
|
2024
Q2 | $80.9K | Hold |
26,958
| – | – | 0.03% | 71 |
|
|
2024
Q1 | $125K | Hold |
26,958
| – | – | 0.05% | 69 |
|
|
2023
Q4 | $112K | Hold |
26,958
| – | – | 0.05% | 69 |
|
|
2023
Q3 | $80.9K | Hold |
26,958
| – | – | 0.04% | 70 |
|
|
2023
Q2 | $66.3K | Hold |
26,958
| – | – | 0.03% | 71 |
|
|
2023
Q1 | $60.9K | Hold |
26,958
| – | – | 0.03% | 69 |
|
|
2022
Q4 | $94.1K | Hold |
26,958
| – | – | 0.05% | 71 |
|
|
2022
Q3 | $998K | Hold |
26,958
| – | – | 0.56% | 46 |
|
|
2022
Q2 | $512K | Hold |
26,958
| – | – | 0.28% | 59 |
|
|
2022
Q1 | $728K | Hold |
26,958
| – | – | 0.32% | 61 |
|
|
2021
Q4 | $607K | Hold |
26,958
| – | – | 0.25% | 64 |
|
|
2021
Q3 | $707K | Hold |
26,958
| – | – | 0.32% | 61 |
|
|
2021
Q2 | $863K | Hold |
26,958
| – | – | 0.4% | 58 |
|
|
2021
Q1 | $949K | Hold |
26,958
| – | – | 0.48% | 55 |
|
|
2020
Q4 | $865K | Hold |
26,958
| – | – | 0.47% | 53 |
|
|
2020
Q3 | $1.01M | Hold |
26,958
| – | – | 0.64% | 49 |
|
|
2020
Q2 | $1.21M | Buy |
+26,958
| New | +$1.21M | 0.82% | 43 |
|